ABBV

NYSE

AbbVie Inc.

Health Care, Biotechnology

$246.04

close 7 Aug 2026

+23.86%

52-week change

$434.78B

market cap

$190.75

$267.47

52-week range

Expected price

$152.44 – $186.31

Current price

$246.04

Signal

Could be overvalued

A historical-multiple reference, never a fair-value claim. The band uses only data public at each date and ends at the latest month — no forward estimates.

Current multiples

P/E (TTM)69.50x

P/S (TTM)6.75x

P/B-73.26x

EV/EBITDA (TTM)28.28x

FCF yield (TTM)4.19%

PEG (TTM, GAAP)—

Context

P/E, own 5-year average59.25x

P/E, sector median29.65x*

Price at 5-year median P/E$163.59*

Indicated dividend yield2.81%

Forward — analyst consensus

Forward P/E (FY2026)17.56x*

Forward P/E (FY2027)15.06x

Forward PEG1.06*

Consensus EPS FY2026 (20 analysts)$14.01

EPS growth (FY2026→FY2027)16.60%

Revenue growth (FY2026)10.57%

Street view

Price target (mean)$273.39*

Target upside11.12%

Ratings (buy / hold / sell)24 / 6 / 1

FY2026 EPS revisions, 30d (up / down)0 / 19

5-year history

Dashed line: average of month-end values

P/E (TTM)

P/S (TTM)

P/B

FCF yield (TTM)

Dividend yield

period to 30 Jun 2026, filed 3 Aug 2026, close 7 Aug 2026

Discounted cash flow

Ten projected years plus a perpetuity, prefilled from filings — a model to argue with, never a fair-value claim.

Free cash flow, last ten years and TTM

5Y CAGR +1.19%10Y CAGR +9.79%

Assumptions

Growth rate, years 1–10%

Perpetual growth%Discount rate%

Base FCF$M

As filed — not assumptions

Current price$246.04

Cash & equivalents$6.57B

Total debt$70.82B

Shares outstanding1.77B

Result

DCF price per share$137.05

Current price$246.04

Margin of safety-44.30%

PV of years 1–10$129.51B

PV of terminal value$176.93B

Equity value$242.19B

Market-implied growth+7.44%

Projected FCF, years 1–10

Hover for PV and growth

Projection detail

Override growth for any year; blank years use the uniform rate

Year	2026	2027	2028	2029	2030	2031	2032	2033	2034	2035	Terminal
Growth, %											2.5
FCF	$18.43B	$18.65B	$18.87B	$19.09B	$19.32B	$19.55B	$19.78B	$20.02B	$20.26B	$20.50B	$381.99B
PV	$17.06B	$15.99B	$14.98B	$14.03B	$13.15B	$12.32B	$11.54B	$10.81B	$10.13B	$9.49B	$176.93B

period to 30 Jun 2026, filed 3 Aug 2026, close 7 Aug 2026